Cargando…
Prostate Cancer Chemoprevention Targeting Men with High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical Small Acinar Proliferation (ASAP): Model for Trial Design and Outcome Measures
In spite of the large number of nutrient-derived agents demonstrating promise as potential chemopreventive agents, most have failed to prove effectiveness in clinical trials. Critical requirements for moving nutrient-derived agents to recommendation for clinical use include adopting a systematic, mo...
Autores principales: | Kumar, Nagi, Crocker, Theresa, Smith, Tiffany, Connors, Shahnjayla, Pow-Sang, Julio, Spiess, Philippe E., Egan, Kathleen, Quinn, Gwen, Schell, Michael, Sebti, Said, Kazi, Aslam, Chuang, Tian, Salup, Raoul, Helal, Mohamed, Zagaja, Gregory, Trabulsi, Edouard, McLarty, Jerry, Fazili, Tajammul, Williams, Christopher R., Schreiber, Fred, Anderson, Kyle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924733/ https://www.ncbi.nlm.nih.gov/pubmed/24533253 |
Ejemplares similares
-
Long-term supplementation of decaffeinated green tea extract does not modify body weight or abdominal obesity in a randomized trial of men at high risk for prostate cancer
por: Kumar, Nagi B., et al.
Publicado: (2017) -
Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison
por: Cui, Kang, et al.
Publicado: (2017) -
Why do we keep reporting high-grade prostatic intraepithelial neoplasia (HGPIN)?
Publicado: (2016) -
Nephrogenic Adenoma of the Prostatic Urethra Mimicking Prostatic and Bladder Carcinomas
por: Beeter, Maria C, et al.
Publicado: (2023) -
A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomy
por: Kumar, Nagi B., et al.
Publicado: (2020)